DR. JAMES J. MCGOVERN, M.D.

Plain English
This study examined how frailty affects survival in patients with oropharyngeal squamous cell cancer (OPSCC). Researchers looked at over 1,000 patients and found that those who were moderately frail lived, on average, 39 months, and severely frail patients lived only 11 months, compared to 82 months for those who were not frail. While frailty impacts survival, other factors like HPV status and performance status are more important indicators. Who this helps: This information is valuable for doctors treating patients with OPSCC, as it helps them understand the role of frailty in survival outcomes.

Plain English
This study focused on creating a special type of gel made from pig bone that can support the growth of bone cells in the lab. They found that these gels, called dECM-MA, could be adjusted to have different strengths, which helped the bone cells grow and develop properly; for instance, when the gel was set to a medium strength of 10 kPa, the bone cells showed increased growth and activity. This matters because it provides a new tool for studying bone diseases and testing new drugs in a way that better mimics real bone environments. Who this helps: This helps researchers, patients with bone diseases, and drug developers.

Plain English
This study looked at the effects of gastric electrical stimulation (GES) on pregnant women who suffer from severe gastroparesis, a condition that affects their stomach's ability to empty. The researchers observed seven pregnancies in six women and found that the average number of hospital visits due to nausea and vomiting decreased as the pregnancy went on, dropping from nine in the first trimester to just one in the third trimester. However, while there were no maternal deaths, safety concerns about the treatment during pregnancy still need to be investigated further. Who this helps: This information is useful for pregnant patients with gastroparesis and their healthcare providers.

Plain English
This study explored how a protein called Sun2 affects lung fibrosis, a condition where lung tissue becomes stiff and scarred. Researchers found that when Sun2 levels are increased in lung cells, it can lead to a surge in the production of proteins that contribute to fibrosis. Specifically, in their experiments, they noted that when Sun2 was not present, lung fibrosis did not develop in mice treated with a scarring agent, underlining its critical role in this process. Who this helps: This benefits patients suffering from lung fibrosis and their doctors by identifying a potential target for new treatments.

Plain English
This study looked at how using CT scans to measure muscle mass can help doctors better identify malnutrition in cancer patients. Researchers found that 40.4% of patients had malnutrition, and those who were well-nourished lived an average of 30.4 months compared to just 13.5 months for those with moderate malnutrition and 6.4 months for severe malnutrition. This is important because it shows that better identifying malnutrition can lead to better treatment and survival outcomes for cancer patients. Who this helps: Cancer patients and their healthcare providers.

Plain English
This study looked at a program called SafetyNet, which paired a recovery coach and a paramedic to help people who had recently overdosed on opioids. The researchers followed 81 patients after their overdoses and found that 25% had another overdose during the follow-up period, but 68% engaged in medications for opioid use disorder, which can lower the risk of future overdoses. This matters because even though the intervention didn’t show significant differences in overdose rates or treatment engagement, a large portion of participants did seek treatment that could save lives. Who this helps: Patients recovering from opioid addiction.

Plain English
This study focused on a severe lung disease called idiopathic pulmonary fibrosis (IPF) and how a specific receptor in cells, known as Toll-like receptor 9 (TLR9), contributes to worsening the condition. The researchers found that when TLR9 is activated by mitochondrial DNA in patients' blood, it leads to increased inflammation and higher risks, with individuals showing a poorer chance of survival without a transplant. Importantly, using a direct method to block TLR9 reduced harmful responses in lab models, indicating a potential new treatment for IPF. Who this helps: Patients with idiopathic pulmonary fibrosis may benefit from this treatment approach.

Plain English
This study looked at how nerves and specific cells called myofibroblasts work together in the lungs of both mice and humans with lung fibrosis, a condition that causes scarring in the lungs. Researchers found that myofibroblasts in fibrotic lungs receive signals from sympathetic nerves, which can lead to more scarring. Understanding this connection is important because it opens new avenues for treating lung fibrosis, a condition that currently has limited treatment options. Who this helps: This discovery benefits patients with lung fibrosis and their doctors by potentially leading to new treatment strategies.

Plain English
This study examined how specific conditions used to prepare bone tissue before implantation affect the growth and quality of human-like bone structures. Researchers found that using a special mineral-rich solution during the preparation phase led to significantly better bone growth and mimicry of real human bone, regardless of the material used, improving outcomes for bone tissue engineering. This is important because it could lead to better treatments in regenerative medicine, making it easier to create effective bone models for research and therapeutic use. Who this helps: Patients needing bone repair or implants, as well as doctors involved in regenerative medicine.

Plain English
In this study, researchers looked at how removing adrenal glands (a surgery called adrenalectomy) affects lung damage caused by a substance called bleomycin in mice. They found that while the overall amount of collagen (a key component of scar tissue) in the lungs didn't change much after the surgery, the surgery did reduce inflammation in the lungs and the number of certain immune cells (lymphocytes and macrophages). This matters because it highlights a connection between the adrenal glands and lung fibrotic disease, suggesting that removing them may help protect against worsening lung damage. Who this helps: This helps patients with lung fibrosis and their doctors by highlighting a potential new treatment approach.

Plain English
This study looked at how frailty affects survival in patients with laryngeal squamous cell cancer, analyzing data from 867 patients in the West of Scotland diagnosed between 2014 and 2020. It found that 78% of patients were considered frail, and those who were severely frail had a median survival of just 23 months compared to 78 months for those not frail. This matters because understanding the link between frailty and survival can help doctors provide better care and treatment options for these patients. Who this helps: Patients with laryngeal cancer and their healthcare providers.

Plain English
This study looked at how a combination of body mass index (BMI), weight loss, and inflammation levels in advanced cancer patients can predict their survival. Researchers analyzed data from 1,303 patients and found that the 3-month survival rates varied significantly: higher BMI and lower weight loss were linked to better outcomes, with survival rates ranging from 74% for those with a BMI over 28 to just 61% for those with a BMI under 20, and 93% survival for low inflammation (mGPS 0) compared to 60% for high inflammation (mGPS 2). This information is important because it helps doctors better understand which patients are at greater risk of dying, allowing for more tailored treatment plans. Who this helps: This helps patients with advanced cancer and their doctors by identifying those who may need more intensive care or support.

Plain English
This study looked at how fat cells (adipocytes) interact with prostate cancer cells, especially when treated with an antiandrogen drug called Enzalutamide. Researchers found that fat cells from different body areas responded differently to the drug. Specifically, prostate cancer cells that depend on hormones changed their behavior more than those that do not, showing altered fat metabolism and insulin-related issues during treatment. This research is important because it helps us understand why some men with advanced prostate cancer struggle with treatment and may provide insights for developing better therapies. Who this helps: This helps patients with advanced prostate cancer and their doctors.

Plain English
This study examined how a part of the immune system called TLR9 helps the body respond to influenza infections and tissue damage caused by the virus. Researchers found that mice without TLR9 had less inflammation early on, but they struggled to clear the virus effectively, resulting in higher levels of the virus persisting in their immune cells and causing ongoing lung damage. In humans, higher levels of TLR9 activity were linked to more severe cases of influenza, particularly in patients admitted to intensive care. Who this helps: This research benefits patients with influenza, especially those at risk of severe illness.

Plain English
This study looked at different tools used to visually assess a skin condition called acanthosis nigricans, which is more common in people with darker skin. The researchers found that the Acanthosis Nigricans Scoring Chart is the best option for tracking how severe the condition is, especially when patients receive treatment. Developing better ways to measure the condition’s severity is important for creating effective treatments and addressing health disparities. Who this helps: This benefits patients with acanthosis nigricans, particularly those with skin of color.

Plain English
This study looked at two methods for collecting bone grafts from sheep to see which was safer for the heart and lungs. The researchers found that both methods led to similar levels of blood loss and had no significant impact on heart or lung function. Since both techniques are safe, the new ARA method shows great promise as a reliable alternative for use in humans. Who this helps: This benefits patients needing bone grafts and the doctors who perform the procedures.

Plain English
This study looked at a scoring system called the Laboratory Cachexia Score (LCAS) to see how well it could predict outcomes for patients with advanced lung cancer, specifically focusing on factors like LDH, CRP, and albumin levels. Researchers found that LCAS was linked to one-year survival rates, with patients showing poorer outcomes if they had higher scores. LCAS proved to be more effective in identifying cachexia (wasting syndrome) and predicting survival than other established scores. Who this helps: This research benefits patients with advanced lung cancer by providing doctors with a better tool to assess their condition and prognosis.

Plain English
This study looked at how systemic inflammation affects the health of 388 patients with advanced cancer, specifically focusing on measures like C-reactive protein (CRP), the modified Glasgow Prognostic Score (mGPS), and the Neutrophil-to-Lymphocyte Ratio (NLR). They found that higher levels of these inflammatory markers were linked to worse outcomes, such as more weight loss and shorter survival times; for instance, CRP and mGPS were significantly associated with weight loss and overall survival (p < 0.001). This matters because understanding and measuring inflammation can help predict which patients are at greater risk and improve their care based on these assessments. Who this helps: This benefits patients and doctors by providing better tools for assessing cancer prognosis and guiding treatment decisions.

Plain English
This study looks at fat cells in bone marrow and how they might influence cancer and bone health. Researchers found that these fat cells can play a significant role in how bones function and may be involved in the development of cancer. They highlight the need for better models to study these interactions, as well as new treatments that could involve targeting these fat cells to improve cancer therapy. Who this helps: This research benefits cancer patients and doctors by offering new insights into treatment strategies.

Plain English
In this study, researchers explored how two different techniques, premineralization and prevascularization, affect the growth of bone and blood vessels in engineered bone tissue. They found that premineralization boosts bone formation, resulting in faster and better-quality bone, while prevascularization helps blood vessels develop but can reduce the overall amount of bone created. The insights from this research are important for improving bone healing and the design of better biomaterials in regenerative medicine. Who this helps: This helps patients needing bone repair and doctors developing treatments for bone-related conditions.

Plain English
This paper examines the concept of "epistemic disobedience," which aims to challenge and change the way public health research is done by breaking away from colonial power dynamics. The authors discuss how this approach can help create fairer and more equitable health practices, and they provide examples of how it can be applied in real-world situations. By emphasizing health equity as a human right, the study shows that changing the way we think about knowledge in health can lead to better outcomes for everyone. Who this helps: This benefits patients and communities seeking fairer health care practices.

Plain English
This editorial discusses insights from a conference on the relationship between migration and health, emphasizing the importance of seeing health as a human right. It highlights the challenges migrants face, including limited access to healthcare and social services, which can lead to poorer health outcomes. Addressing these issues is crucial for improving the well-being of migrants and ensuring they receive the care they need. Who this helps: This helps migrants and healthcare providers.

Plain English
This study looked at how tumor necrosis, inflammation in the body, and body makeup affect the survival of colon cancer patients. Researchers found that 73% of the 473 patients studied had tumor necrosis, which was linked to various factors including age and overall health. Specifically, older patients and those with higher inflammation levels had worse survival odds, suggesting these factors significantly influence outcomes. Who this helps: Patients with colon cancer and their healthcare providers.

Plain English
This study looked at a special protein called cGAS in the lungs of patients with a serious lung disease linked to systemic sclerosis. Researchers found that levels of cGAS were higher in the lung tissues of these patients, which was connected to increased inflammation and scarring in the lungs. They discovered that blocking cGAS led to a decrease in harmful cell activity, suggesting that targeting this protein could be a new way to treat this lung disease. Who this helps: This research benefits patients suffering from systemic sclerosis-associated lung disease by offering potential new treatment options.

Plain English
This study looked at how mitochondrial DNA (mtDNA) in the blood of patients with sarcoidosis relates to feelings of fatigue. Researchers found that higher levels of mtDNA were strongly linked to increased fatigue, especially in patients with more severe forms of the disease. This connection matters because understanding the role of mtDNA could lead to new treatment options for sarcoidosis and similar conditions, which currently have limited therapies. Who this helps: This helps patients with sarcoidosis and potentially others experiencing chronic fatigue.

Plain English
This study looked at using a simple and less expensive test called nocturnal pulse oximetry (NPO) to identify obstructive sleep apnea (OSA) in children aged 1 to 16, compared to the more complex and costly cardiorespiratory polygraphy (CRP). Out of 322 children tested, nearly 45% had at least one episode of OSA per hour, with 8.7% experiencing more severe cases. The findings show that certain measurements from NPO, specifically an index called ODI3, can reliably indicate moderate to severe OSA, making it a useful tool when CRP may not be available. Who this helps: This helps doctors and parents of children who might have sleep apnea.

Plain English
This study looked at two different methods of collecting bone grafts from sheep to see if they caused fat particles to enter the bloodstream, which can lead to serious lung problems. Researchers found that both the traditional Reamer-Irrigator-Aspirator (RIA 2) system and the new aspirator-based method resulted in similar amounts of fat entering the blood and did not significantly raise levels of blood clotting markers. This means that both methods are equally safe in terms of risks associated with fat embolism. Who this helps: This research benefits doctors and patients requiring bone graft procedures.

Plain English
This study looked at how a specific sensor in the immune system, called TLR9, helps the body respond to influenza virus infections. Researchers found that mice without TLR9 had a weaker immune response, allowing the virus to persist longer and causing more lung damage—these mice showed higher levels of inflammation and took longer to recover. In humans, higher TLR9 activity in blood samples from hospitalized flu patients was linked to more severe illness, indicating that TLR9 plays an important role in fighting the virus. Who this helps: This helps patients with influenza and doctors treating them.

Plain English
This study looked at body composition in patients with abdominal aortic aneurysm (AAA) versus colorectal cancer (CRC) using CT scans. It found that 33% of CRC patients had low muscle density compared to just 6% of AAA patients, and both groups had a similar 51% prevalence of low muscle mass. The results highlight that older age and inflammation are key factors in losing muscle mass and density, which can affect treatment and recovery. Who this helps: This information benefits doctors in treating cancer and non-cancer patients by understanding their muscle health.

Plain English
This study looked at how the size of the liver affects the survival of patients with non-metastatic colon cancer after surgery. Researchers found that of 359 patients, 81% were alive three years after their operations. They also discovered that the size of the liver can be consistently measured using a new imaging method, which could help in future cancer research. Who this helps: This benefits patients with colon cancer and their doctors.

Plain English
This study looked at a new tool called the cachexia index (CXI) to predict outcomes for patients with advanced esophageal or gastric cancer undergoing chemotherapy and surgery. Researchers found that patients with a low CXI had a higher risk of their disease worsening during treatment (28% compared to 12%) and a significantly shorter life expectancy (average of 15 months versus 57 months for those with a normal CXI). Knowing a patient's CXI could help doctors make better treatment decisions and improve patient outcomes. Who this helps: This helps doctors and patients with advanced esophageal or gastric cancer.

Plain English
This study looked at how a substance called lactate dehydrogenase (LDH) in the blood relates to cancer cachexia, a condition where cancer patients lose a lot of weight and muscle. Researchers found that high levels of LDH were significantly linked to low body mass index (BMI), inflammation, and poor overall survival rates, with those having high LDH seeing a 2.25 times higher risk of death compared to those with normal levels. Understanding this link can help doctors better identify risk factors in cancer patients and make more informed decisions about their treatment. Who this helps: This helps patients with cancer and their doctors.

Plain English
This study looked at how exercise tests, body composition analyzed through CT scans, and inflammation relate to survival after surgery for abdominal aortic aneurysm (AAA). Researchers found that patients with higher sarcopenia scores, which indicate lower muscle mass, had shorter survival times: 80.1 months for low sarcopenia, 70.3 months for medium, and 63.8 months for high sarcopenia. Inflammation levels did not affect exercise test results but were linked to increased risk of death, showing that monitoring body composition can help predict long-term outcomes. Who this helps: This benefits patients undergoing surgery for AAA and their doctors by providing insights on factors that could impact survival.

Plain English
This study looked at how often biomarkers—objective measures from body fluids—are used as endpoints in clinical trials for cancer cachexia, a condition that causes significant weight loss and muscle wasting in cancer patients. Out of nearly 6,000 studies, 52 trials involving over 6,500 participants used biomarkers, with most trials focusing on drug treatments rather than nutritional interventions. The findings highlight that while many different biomarkers were used, only a few showed strong links to clinical benefits; for example, levels of IGFBP-3 and IGF-1 increased in trials and correlated with improvements in lean body mass, which is crucial for patient health. Who this helps: This research benefits patients dealing with cancer cachexia and healthcare providers looking for effective treatments.

Plain English
Researchers studied a new method for collecting bone grafts, named the ARA concept, to see if it works as well as the current standard method, called RIA 2. They found that the bone grafts collected using the ARA method had the same ability to help bone growth as those collected with the RIA 2 system, showing no significant differences in new bone formation. This is important because it offers a viable alternative for harvesting bone grafts, which are necessary for effective bone regeneration treatments. Who this helps: This helps patients needing bone repair, as well as doctors who perform these procedures.

Plain English
This study looked at a new type of gel made from liver tissue that can better mimic the environment of liver cells in lab settings. Researchers found that their gel, created using a special technique, allows control over its strength and other properties, with Young's modulus ranging from 1 to 7 kPa, making it more consistent and effective than traditional gels. This is important because it helps liver cells grow better and function more like they would in the body, which is valuable for testing new drugs and understanding liver diseases. Who this helps: This benefits researchers and pharmaceutical companies working on liver diseases and drug testing.

Plain English
This study examined how age affects body composition, specifically skeletal muscle index (SMI) and skeletal muscle density (SMD), in patients with colon cancer. It found that as age increased, the percentage of patients with low SMI rose from 39% in those under 50 to 74% in those over 80, and for SMD, it increased from 27% to 92% in the same age groups. This is important because it highlights that older patients are more likely to have lower muscle levels, which can impact their overall health and recovery from cancer. Who this helps: This helps older colon cancer patients by identifying their increased risk for low muscle levels, which may influence treatment plans.

Plain English
This research paper looks at how cancer affects patients, especially focusing on cachexia, a serious condition where patients lose weight and muscle. The review found that there are different ways to measure this condition, and while the Global Leadership Initiative on Malnutrition (GLIM) framework can help in assessing and managing it, there are challenges in consistently using these measurements. This matters because better monitoring of cachexia can lead to improved treatments and quality of life for cancer patients. Who this helps: This helps cancer patients and their healthcare providers.

Plain English
This study looks into how to diagnose cachexia, a type of malnutrition linked to inflammation. Researchers recommend using a specific blood test called C-reactive protein (CRP) to measure inflammation and identify this condition. They argue that this approach could improve diagnosis, especially for cancer patients, who often experience cachexia due to their illness. Who this helps: Patients with cancer and healthcare providers.

Plain English
This study looked at how systemic inflammation affects survival in patients with advanced non-small cell lung cancer (NSCLC) who were in good health and receiving palliative radiotherapy. Researchers found that 98% of the 479 patients studied died during follow-up, with a median survival time of 5 months. Key inflammation indicators like the C-reactive protein-albumin ratio (CAR) and modified Glasgow prognostic score (mGPS) were linked to survival rates, showing that these measures can help predict patient outcomes. Who this helps: This helps patients and doctors by providing insights on how to better evaluate prognosis and tailor treatment options.

Plain English
Researchers tested a new tool called the Early Communication Indicator-Autism (ECI-A) to measure how young autistic children communicate while playing. In a study with 17 children, the ECI-A showed consistent scoring from different evaluators, and parents were able to use it effectively with some guidance. This tool can help better understand and support the communication skills of young children with autism in both clinical and research settings. Who this helps: This benefits young autistic children and their families.

Plain English
This study looked at how a protein called cGAS is involved in lung issues related to systemic sclerosis, specifically a condition known as interstitial lung disease (SSc-ILD). Researchers found that cGAS levels were higher in lung tissues from SSc-ILD patients, which led to increased inflammation and scarring (fibrosis). By using special inhibitors, they demonstrated that blocking cGAS could reduce inflammation and improve lung conditions in both lab samples and a mouse model. Who this helps: This helps patients with systemic sclerosis and related lung issues by pointing to new treatment options.

Plain English
This study looked at a new way to collect bone grafts from the center of bones, comparing it to an existing system called the Reamer-Irrigator-Aspirator (RIA). Researchers found that both methods were effective, with the new technique successfully preserving important growth factors that help bones heal. This is significant because maintaining these healing elements can improve recovery outcomes for patients needing bone repairs. Who this helps: Patients undergoing procedures that require bone grafts.

Plain English
This study looked at how giving patients with severe pancreatitis intravenous (IV) fluids affects their chances of surviving the first 30 days after being admitted to the hospital. Researchers found that patients with severe pancreatitis who received more fluids (about 4,000 mL in the first 24 hours) had lower mortality rates compared to those who received less (around 2,750 mL), and the aggressive fluid treatment led to a 34% decrease in the odds of dying. This highlights the importance of giving the right amount of IV fluids to improve survival chances in severe pancreatitis cases. Who this helps: This helps patients with severe pancreatitis and their doctors.

Plain English
Researchers studied new 3D-printed scaffolds made from a special plastic (polycaprolactone) combined with bone-like material (hydroxyapatite) to help regenerate bone tissue. They found that these scaffolds were very porous (73% air space) and did not break down much over six months. When tested in rats, the scaffolds promoted the growth of healthy blood vessels and bone without causing negative reactions in the surrounding tissue. Who this helps: This benefits patients needing bone regeneration, including those with injuries or bone diseases.

Plain English
This study looked at how certain health factors affect survival in patients with advanced non-small cell lung cancer (NSCLC) who were treated with a medication called nivolumab. Researchers found that the average survival time after starting treatment was 15 months. They also discovered that patients' performance status and low albumin levels were important indicators of how long they might live after receiving this treatment. Who this helps: This benefits patients with advanced NSCLC and their healthcare providers in understanding better predictors of survival.